AI aids T2D insulin dosing

A patient-facing voice-based conversational artificial intelligence (VBAI) application that provided autonomous basal insulin titration has been found to improve time to optimal insulin dosing, insulin

Read More »

New boost to cure T1D

The Type 1 Diabetes Grand Challenge – a partnership between the Steve Morgan Foundation, Diabetes UK and JDRF UK – has announced that it has

Read More »

New Charcot Disease treatment

The French National Agency for Medicines and Health Products Safety (ANSM) has conditionally authorized AMX0035, a new medication developed by the American laboratory Amylyx Pharmaceuticals

Read More »